With ongoing growth across the board, plan sponsors are continuously searching for ways to minimize the impact on their bottom line.
Lee Feigert, PharmD, MSPBA
Advertisement
Articles by Lee Feigert, PharmD, MSPBA
There are currently firms working to use artificial intelligence in hopes that it could contribute to minimizing the impact of the opioid epidemic.
The world is rapidly moving towards the adoption and seamless integration of artificial intelligence (AI), including machine learning as a subset of AI, throughout our daily lives.
Advertisement
Latest Updated Articles
The Future is Now: Artificial Intelligence and Machine Learning in Specialty PharmacyPublished: January 9th 2019 | Updated:
Artificial Intelligence Can be Leveraged to Minimize Casualties of the Opioid EpidemicPublished: April 11th 2019 | Updated:
Co-pay Accumulator Programs: Behind the ControversyPublished: July 22nd 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Addressing Drug Resistance in Lung Cancer
2
From Mutation to Medicine: Targeted Therapies in Lung Cancer
3
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
4
TAR-200 Intravesical System Demonstrates Sustained Bladder Exposure in BCG-Unresponsive NMIBC
5
